News & Updates

Can breast cancer survivors temporarily stop endocrine therapy to attempt pregnancy?
Can breast cancer survivors temporarily stop endocrine therapy to attempt pregnancy?
05 Jan 2023 byRoshini Claire Anthony

Young breast cancer survivors could safely temporarily stop adjuvant endocrine therapy (ET) to attempt pregnancy, according to primary results of the POSITIVE* trial presented at SABCS 2022.

Can breast cancer survivors temporarily stop endocrine therapy to attempt pregnancy?
05 Jan 2023
Postoperative neutropaenia tied to early CRBSI in children with leukaemia
Postoperative neutropaenia tied to early CRBSI in children with leukaemia
05 Jan 2023 byStephen Padilla

Paediatric patients with acute myeloid leukaemia and other leukaemias (AML/OLs), especially those with persistent neutropaenia during the first 30 postoperative days, are at increased risk of early catheter-related bloodstream infections (CRBSIs), according to a Singapore study.

Postoperative neutropaenia tied to early CRBSI in children with leukaemia
05 Jan 2023
SG kids prone to multisystem inflammatory syndrome amid high COVID-19 transmission
SG kids prone to multisystem inflammatory syndrome amid high COVID-19 transmission
04 Jan 2023
Edoxaban prevents thromboembolism in children with cardiac disease
Edoxaban prevents thromboembolism in children with cardiac disease
04 Jan 2023

Edoxaban may be used as an alternative treatment for thromboembolism (TE) prevention in children with cardiac disease showing low rates of clinically relevant bleeding and TE, suggests a study. Some of its advantages include once-daily dosing and infrequent monitoring requirement.

Edoxaban prevents thromboembolism in children with cardiac disease
04 Jan 2023